Valuation : Virbac

Market Cap 2.65B 3.08B 2.49B 2.27B 4.24B 292B 4.26B 29.51B 11.42B 149B 11.56B 11.31B 475B P/E 2026 *
15.5x
P/E 2027 * 14x
Enterprise Value 2.77B 3.23B 2.61B 2.38B 4.44B 306B 4.47B 30.92B 11.96B 156B 12.12B 11.85B 498B EV / Sales 2026 *
1.79x
EV / Sales 2027 * 1.65x
Free-Float
49.03%
Yield 2026 *
0.55%
Yield 2027 * 0.65%
1 day+0.16%
1 week-1.70%
Current month-1.70%
1 month-7.68%
3 months-9.52%
6 months-8.87%
Current year-10.16%
1 week 313
Extreme 313
326
1 month 313
Extreme 313
346
Current year 313
Extreme 313
385.5
1 year 296
Extreme 296
385.5
3 years 242
Extreme 242
399
5 years 215.5
Extreme 215.5
447
10 years 102.86
Extreme 102.85567
447
Manager TitleAgeSince
Chief Executive Officer 46 2025-08-31
Chief Executive Officer 50 2024-09-26
Chief Operating Officer 64 2021-12-31
Director TitleAgeSince
Chairman 61 2006-03-31
Director/Board Member 68 2010-07-27
Director/Board Member 65 2017-09-04
Change 5-day change 1-year change 3-year change Capi.($)
+1.51%-1.70% - - 3.06B
-2.97%-4.59%-52.02%-60.83% 31.33B
-2.16%+0.21%+30.06%+105.22% 12.24B
+2.32%+2.08%-9.82%+7.56% 3.96B
+0.64%-2.02%-2.47%+18.35% 3.06B
+0.98%-1.58%+52.02%+34.71% 2B
-0.44%-3.28%+11.60%+13.17% 1.88B
-2.46%-1.14%-5.42%+198.96% 1.55B
-0.33%+4.74%-16.23%+0.22% 1.23B
+2.27%+5.42%-3.23%-37.34% 1.07B
Average -0.17%+1.15%+0.50%+31.11% 6.48B
Weighted average by Cap. -1.76%-0.35%-20.82%-2.88%

Financials

2026 *2027 *
Net sales 1.55B 1.8B 1.46B 1.33B 2.48B 171B 2.5B 17.29B 6.69B 87.41B 6.77B 6.63B 278B 1.65B 1.92B 1.55B 1.41B 2.64B 182B 2.65B 18.36B 7.1B 92.84B 7.19B 7.04B 295B
Net income 171M 199M 161M 147M 274M 18.87B 276M 1.91B 738M 9.64B 747M 731M 30.69B 190M 220M 178M 163M 304M 20.9B 305M 2.11B 817M 10.68B 828M 810M 33.99B
Net Debt 127M 147M 119M 109M 203M 13.98B 204M 1.41B 547M 7.14B 554M 541M 22.73B 75.16M 87.41M 70.71M 64.53M 120M 8.29B 121M 838M 324M 4.24B 328M 321M 13.48B
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
6,442
Date Price Change Volume
26-09-08 318.50 +1.51% 0
26-09-07 €314.50 -1.10% 0
26-09-04 €318.00 -1.40% 1
26-09-03 €322.50 +0.31% 157
26-09-02 €321.50 -0.77% 637
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
316.00EUR
Average target price
411.88EUR
Spread / Average Target
+30.34%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!